| || |
08th November 2013
| ||Press Releases |
MOCON, Inc. (NASDAQ:MOCO) announced today that on October 25, 2013, the Minneapolis/St. Paul Business Journal named MOCON, Inc. to its list of the top twenty-five fastest growing public companies in Minnesota. MOCON was ranked number ten on the list which assessed the companies by annualized three year revenue growth. MOCON’s average annual growth rate over its last three fiscal years was 23.3%.
ProNAi Therapeutics, Inc. a leader in nucleic acid therapeutics, announced that data from its ongoing Phase II clinical study of PNT2258, a novel BCL2 inhibitor, will be presented at the 55th Annual Meeting of the American Society of Hematology (ASH), held in New Orleans December 7-10, 2013. “We are very encouraged by the safety profile and the anti-tumor responses in patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) treated with PNT2258,” stated Rich Messmann, ProNAi’s Chief Medical Officer.
Santarus, Inc. (NASDAQ:SNTS) and Pharming Group NV (NYSE Euronext: PHARM) announced that new data from an open-label extension of the pivotal Phase III clinical study with RUCONEST® (recombinant human C1 esterase inhibitor, or rhC1INH) will be featured in a poster presentation on November 9 & 10, 2013 at the 2013 American College of Allergy, Asthma & Immunology Annual Scientific Meeting at the Convention Center in Baltimore, Maryland.
Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today announced the successful enrollment of the 100th patient into the Natural History Study of Duchenne muscular dystrophy (DMD). The goal of this observational study is to characterize DMD at various stages of progression using the same measures used in ongoing clinical studies, such as the "six minute walk test." No medication is being tested in this study.
| ||Articles |
One of the premium industrial segments ever and one such industry on which many nations across the globe have relied upon for boosting the economic development is Pharma Industry. However, when we dwell in to the insights, this is one of the most regulated industries and of course it has to be, as it is directly related to the lives of many.
Recommendations can be gained from many sources such as a primary care doctor or friends who have seen particular psychiatrists. Getting a recommendation from a primary care doctor is a good idea, as they have a good insight into the situation and can possibly guide people towards the right psychiatrist for their particular needs.
Everybody believes that informed consent makes clinical research ethical. However, informed consent is neither necessary nor sufficient for ethical clinical research. Drawing on the basic philosophies underlying major codes, declarations, and other documents relevant to research with human subjects, The aspects which make Clinical Research Ethical:
| ||Reports |
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
| ||Suppliers |
The Pamasol company was formed in Switzerland and for 50 years has been setting pioneering technological standards in the aerosol industry. In the future as well, Pamasol is depending on high quality and gearing itself to its successful origins in mechanical engineering.
PCI Analytics Pvt. Ltd. is involved in manufacturing wide range of Gas handling Equipments, analytical Instruments, Attachments, and Accessories etc. since 1994. PCI Analytics Pvt. Ltd. is one of the leading suppliers of Accessories, consumables, spares for GC, HPLC, FTIR, AAS, ICP-MS, UV-VISIBLE Spectrophoto meter and other Analytical Instruments.
Bioquell specialise in the design, manufacture and application of complete bio-decontamination solutions for airborne and surface contamination in the healthcare, life sciences, food production and defence sectors. Bioquell's unique hydrogen peroxide vapour (HPV) bio-decontamination technology has been used across the globe to eradicate problematic bacteria, viruses and fungi, throughout a wide range of applications.
| ||Event and Exhibitions |
Clinical Trial Supply Southern California returns for its 4th year and after the success of last year’s conference, the 2013 event is set to be the perfect forum for discussion and debate into the biggest challenges facing the clinical supply chain.
As the pharmaceutical industry as a whole takes an ever-increasing look at the advent and implications of biosimilar medicines, now is an important time to ensure you are at the forefront of knowledge in the biosimilar space. Make sure you understand the full scope of considerations in developing biosimilars
As Europe’s longest running commercial congress, it is officially Europe’s largest forum bridging clinical, designation, market access, reimbursement and corporate development aims. With unrivalled endorsement from industry’s leading rare disease and orphan drug developers, this event brings the Who’s Who of the orphan drug Biopharma community.
Click here to unsubscribe from the newsletter
Ochre Media Pvt. Ltd., Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Andhra Pradesh, India.